MANPREET SINGH: Open Payments
NPI 1205172186 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,673 in 121 payments from 21 companies in 2025. Trend: 2023 $1,015 · 2024 $1,402 · 2025 $3,673
Food & beverage: $3,561Education: $112
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $510 |
| Janssen Biotech, Inc. | 13 | $401 |
| Galderma Laboratories, L.P. | 13 | $380 |
| ABBVIE INC. | 13 | $317 |
| GENZYME CORPORATION | 5 | $257 |
| Lilly USA, LLC | 4 | $200 |
| Arcutis Biotherapeutics, Inc. | 3 | $200 |
| Amgen Inc. | 4 | $185 |
| PFIZER INC. | 15 | $184 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $170 |
Products named: Bimzelx, TREMFYA, DUPIXENT, AKLIEF, Zoryve, EBGLYSS, CIBINQO, NEMLUVIO.
Industry payments across NV — which companies pay providers there.
